New York Times
The Food and Drug Administration for the first time has authorized a genetic testing company to offer screenings for three breast cancer mutations common in Ashkenazi Jews, giving consumers the ability to initiate testing at home and see results
FDA OKs 23andMe home breast cancer DNA test, with
23andMe gets FDA approval to report breast cancer risk without a doctorWashington Post
23andMe Gets FDA Green Light to Sell First Consumer DNA Test for Cancer RiskGizmodo -Reuters -The Verge -Business Insider
all 48 news articles …read more

Source: HEALTH